MarketScreener Editorial Features Oramed Pharmaceuticals, Inc. OTC Bulletin Board
Equities
US68403P1049
End-of-day quote
Other stock markets
|
||
- USD | - |
05-15 | Compugen Names David Silberman CFO | MT |
05-09 | Oramed Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
- Stock Market
- Equities
- ORMP Stock
- Stock
- News Oramed Pharmaceuticals, Inc.
- MarketScreener Editorial Features